Myriad Genetics Inc. Earnings

Myriad Genetics Inc.’s revenue fell -3.12% since last year same period to $195.9Mn in the Q1 2025. On a quarterly growth basis, Myriad Genetics Inc. has generated -6.98% fall in its revenue since last 3-months.

Myriad Genetics Inc.’s net profit jumped 99.62% since last year same period to $-0.1Mn in the Q1 2025. On a quarterly growth basis, Myriad Genetics Inc. has generated 99.76% jump in its net profits since last 3-months.

Myriad Genetics Inc.’s net profit margin jumped 99.6% since last year same period to -0.05% in the Q1 2025. On a quarterly growth basis, Myriad Genetics Inc. has generated 99.75% jump in its net profit margins since last 3-months.

Myriad Genetics Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.01 - a 169.88% jump from last quarter’s estimates.

Myriad Genetics Inc.’s earning per share (EPS) estimates for the current year stand at 0.01.

Myriad Genetics Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Myriad Genetics Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.